32421689|t|Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer's disease.
32421689|a|Accumulating data suggest cerebrospinal fluid (CSF) neurogranin (Ng) as a potential biomarker for cognitive decline and neurodegeneration in Alzheimer disease (AD). To investigate whether the CSF Ng can be used for diagnosis, prognosis, and monitoring of AD, we examined 111 cognitively normal (CN) controls, 193 mild cognitive impairment (MCI) patients and 95 AD patients in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Correlations were tested between baseline CSF Ng levels and baseline core AD biomarkers and longitudinal glucose metabolism, brain atrophy and cognitive decline. We detected that CSF Ng levels increased with disease severity, and correlated with phosphorylated tau and total tau levels within each diagnostic group. High baseline CSF Ng levels correlated with longitudinal reductions in cortical glucose metabolism within each diagnostic group and hippocampal volume within MCI group during follow-up. In addition, high baseline CSF Ng levels correlated with cognitive decline as reflected by decreased cognitive scale scores. The CSF Ng levels predicted future cognitive impairment (adjusted hazard ratio:3.66, 95%CI: 1.74-7.70, P = 0.001) in CN controls. These data demonstrate that CSF Ng offers diagnostic utility for AD and predicts future cognitive impairment in CN individuals and, therefore, may be a useful addition to the current AD biomarkers.
32421689	35	46	neurogranin	Gene	4900
32421689	73	90	neurodegeneration	Disease	MESH:D019636
32421689	94	113	Alzheimer's disease	Disease	MESH:D000544
32421689	167	178	neurogranin	Gene	4900
32421689	180	182	Ng	Gene	4900
32421689	213	230	cognitive decline	Disease	MESH:D003072
32421689	235	252	neurodegeneration	Disease	MESH:D019636
32421689	256	273	Alzheimer disease	Disease	MESH:D000544
32421689	275	277	AD	Disease	MESH:D000544
32421689	311	313	Ng	Gene	4900
32421689	370	372	AD	Disease	MESH:D000544
32421689	433	453	cognitive impairment	Disease	MESH:D003072
32421689	455	458	MCI	Disease	MESH:D060825
32421689	460	468	patients	Species	9606
32421689	476	478	AD	Disease	MESH:D000544
32421689	479	487	patients	Species	9606
32421689	495	514	Alzheimer's Disease	Disease	MESH:D000544
32421689	600	602	Ng	Gene	4900
32421689	628	630	AD	Disease	MESH:D000544
32421689	659	666	glucose	Chemical	MESH:D005947
32421689	679	692	brain atrophy	Disease	MESH:C566985
32421689	697	714	cognitive decline	Disease	MESH:D003072
32421689	737	739	Ng	Gene	4900
32421689	815	818	tau	Gene	4137
32421689	829	832	tau	Gene	4137
32421689	888	890	Ng	Gene	4900
32421689	950	957	glucose	Chemical	MESH:D005947
32421689	1028	1031	MCI	Disease	MESH:D060825
32421689	1087	1089	Ng	Gene	4900
32421689	1113	1130	cognitive decline	Disease	MESH:D003072
32421689	1189	1191	Ng	Gene	4900
32421689	1216	1236	cognitive impairment	Disease	MESH:D003072
32421689	1343	1345	Ng	Gene	4900
32421689	1376	1378	AD	Disease	MESH:D000544
32421689	1399	1419	cognitive impairment	Disease	MESH:D003072
32421689	1494	1496	AD	Disease	MESH:D000544
32421689	Positive_Correlation	4137	4900
32421689	Negative_Correlation	MESH:D005947	4900
32421689	Association	MESH:D019636	4900
32421689	Association	MESH:D000544	4900
32421689	Association	MESH:D003072	4900

